Back to Browse Journals » International Journal of Nephrology and Renovascular Disease » Volume 4

Diabetic microvascular complications: possible targets for improved macrovascular outcomes

Authors John A D’Elia, George Bayliss, Bijan Roshan, et al

Published 22 December 2010 Volume 2011:4 Pages 1—15


Review by Single-blind

Peer reviewer comments 3

John A D’Elia1, George Bayliss1,2, Bijan Roshan1, Manish Maski1, Ray E Gleason1, Larry A Weinrauch1
1Renal Unit, Joslin Diabetes Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 2Department of Medicine, Rhode Island Hospital, Alpert School of Medicine, Brown University, Providence, RI, USA

Abstract: The results of recent outcome trials challenge hypotheses that tight control of both glycohemoglobin and blood pressure diminishes macrovascular events and survival among type 2 diabetic patients. Relevant questions exist regarding the adequacy of glycohemoglobin alone as a measure of diabetes control. Are we ignoring mechanisms of vasculotoxicity (profibrosis, altered angiogenesis, hypertrophy, hyperplasia, and endothelial injury) inherent in current antihyperglycemic medications? Is the polypharmacy for lowering cholesterol, triglyceride, glucose, and systolic blood pressure producing drug interactions that are too complex to be clinically identified? We review angiotensin–aldosterone mechanisms of tissue injury that magnify microvascular damage caused by hyperglycemia and hypertension. Many studies describe interruption of these mechanisms, without hemodynamic consequence, in the preservation of function in type 1 diabetes. Possible interactions between the renin–angiotensin–aldosterone system and physiologic glycemic control (through pulsatile insulin release) suggest opportunities for further clinical investigation.

Keywords: angiotensin-converting enzyme inhibitor, pulsatile insulin, diabetic nephropathy, cardiac autonomic neuropathy, podocytes, beta cells

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Other articles by this author:

The autonomic nervous system and renal physiology

D'Elia JA, Weinrauch LA

International Journal of Nephrology and Renovascular Disease 2013, 6:149-160

Published Date: 30 August 2013

Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney

John A D’Elia, Bijan Roshan, Manish Maski, et al

International Journal of Nephrology and Renovascular Disease 2009, 2:39-49

Published Date: 6 November 2009

Readers of this article also read:

Relationships between craniocervical posture and pain-related disability in patients with cervico-craniofacial pain

López-de-Uralde-Villanueva I, Beltran-Alacreu H, Paris-Alemany A, Angulo-Díaz-Parreño S, La Touche R

Journal of Pain Research 2015, 8:449-458

Published Date: 30 July 2015

Drug-induced impairment of renal function

Pazhayattil GS, Shirali AC

International Journal of Nephrology and Renovascular Disease 2014, 7:457-468

Published Date: 12 December 2014

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food

Tham J, Walder M, Melander E, Odenholt I

Infection and Drug Resistance 2012, 5:143-147

Published Date: 16 October 2012

Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells

Zhou H, Yang L, Li H, Gong H, Cheng L, Zheng H, Zhang L, Lan Y

International Journal of Nanomedicine 2012, 7:4649-4660

Published Date: 22 August 2012


Hong SH, Kim JE, Kim YK, Minai-Tehrani A, Shin JY, Kang B, Kim HJ, Cho CS, Chae C, Jiang HL, Cho MH

International Journal of Nanomedicine 2012, 7:3069-3070

Published Date: 20 June 2012

Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles

Corem-Salkmon E, Ram Z, Daniels D, Perlstein B, Last D, Salomon S, Tamar G, Shneor R, Guez D, Margel S, Mardor Y

International Journal of Nanomedicine 2011, 6:1595-1602

Published Date: 3 August 2011

Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis

Coventry BJ, Weightman MJ, Skinner JM, Bradley J

Cancer Management and Research 2011, 3:101-108

Published Date: 18 April 2011

Recent advances of chitosan nanoparticles as drug carriers

Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL

International Journal of Nanomedicine 2011, 6:765-774

Published Date: 11 April 2011

Role of aliskiren in blood pressure control and renoprotection

Hernán Trimarchi

International Journal of Nephrology and Renovascular Disease 2011, 4:41-48

Published Date: 22 March 2011